[BGLC] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 44.60%
YoY- -126.10%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 2,567 2,377 2,840 2,575 2,485 3,029 3,245 -14.50%
PBT -275 -53 -127 -67 -140 31 197 -
Tax -16 16 30 10 -2 14 108 -
NP -259 -69 -157 -77 -139 17 89 -
Tax Rate - - - - - -45.59% -54.72% -
Total Cost 2,826 2,446 2,997 2,652 2,624 3,012 3,156 -7.11%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -10.10 -2.91 -5.53 -3.01 -5.58 0.56 2.75 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.02 -0.00 -0.01 -0.01 -0.01 0.00 0.01 -
EPS Diluted -0.02 -0.00 -0.01 -0.01 -0.01 0.00 0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.